Private Trust Company’s Bio-Techne TECH Stock Holding History

Private Trust Company’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.48K	Buy	+21	New	+$1.13K	﹤0.01%	2548
2025 Q3	–	Sell	-151	Closed	-$7.77K	–	2664
2025 Q2	$7.77K	Buy	151 +3	+2%	+$151	﹤0.01%	1900
2025 Q1	$8.68K	Hold	148	–	–	﹤0.01%	1850
2024 Q4	$10.7K	Sell	148 -29	-16%	-$2.13K	﹤0.01%	1732
2024 Q3	$14.1K	Sell	177 -44	-20%	-$3.31K	﹤0.01%	1597
2024 Q2	$15.8K	Buy	221 +62	+39%	+$4.56K	﹤0.01%	1524
2024 Q1	$11.2K	Buy	159 +2	+1%	+$143	﹤0.01%	1624
2023 Q4	$12.1K	Buy	157 +19	+14%	+$1.25K	﹤0.01%	1582
2023 Q3	$9.39K	Hold	138	–	–	﹤0.01%	1623
2023 Q2	$11.3K	Buy	138 +9	+7%	+$723	﹤0.01%	1574
2023 Q1	$9.57K	Buy	129 +9	+8%	+$694	﹤0.01%	1597
2022 Q4	$10K	Buy	120 +8	+7%	+$635	﹤0.01%	1565
2022 Q3	$8K	Sell	112 -20	-15%	-$1.73K	﹤0.01%	1546
2022 Q2	$11K	Buy	+132	New	+$12.4K	﹤0.01%	1472

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Private Trust Company's TECH Position: Q2 2026 in Review

Private Trust Company opened a new position in Bio-Techne (TECH) in Q2 2026: 21 shares worth $1.48K. The stake represents ﹤0.01% of the portfolio and ranks #2548 among its holdings. This is a return to the name: Private Trust Company previously reported a position in TECH as recently as Q2 2025.

Private Trust Company first reported a position in TECH in Q2 2022 and has held it in 14 quarters since. The position peaked at $15.8K in Q2 2024. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Private Trust Company held 21 shares of Bio-Techne worth $1.48K as of Q2 2026.
Bio-Techne was a new Private Trust Company position in Q2 2026.
Bio-Techne made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #2548 holding.
Private Trust Company first reported a position in Bio-Techne in Q2 2022 and has held it in 14 quarters since.
Private Trust Company's Bio-Techne position peaked at $15.8K in Q2 2024.
597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.